CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations.
Soo Lim
J Korean Diabetes. 2019;20(3):127-135.   Published online October 2, 2019
DOI: https://doi.org/10.4093/jkd.2019.20.3.127

Excel Download

Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations
Soo Lim
The Journal of Korean Diabetes. 2019;20(3):127   Crossref logo
Link1 Link2 Link3
Emerging Safety Issues of Dipeptidyl Peptidase-4 Inhibitors and Sodium Glucose Cotransporter 2 Inhibitors: How to Interpret and Apply in Clinical Practice
Nam Hoon Kim, Sin Gon Kim
The Journal of Korean Diabetes. 2017;18(3):135   Crossref logo
Link1 Link2 Link3
Sodium-Glucose Cotransporter 2 Inhibitors
George Dailey, Lauren H. S. Clarine, Renil Marie Rodriguez-Martinez
The Diabetes Textbook. 2019;531-539   Crossref logo
Link1
Sodium-glucose Cotransporter 2 Inhibitors and Anemia Among Diabetic Patients in Real Clinical Practice: a Retrospective Observational Study.
. 2021;   Crossref logo
Link1 Link2
Important Dietary Considerations for Sodium-Glucose Cotransporter 2 Inhibitors
Angelina Anthamatten
The Journal for Nurse Practitioners. 2023;19(3):104527   Crossref logo
Link1 Link2
Physicians’ Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors
Serge A. Jabbour, Nasrien E. Ibrahim, Christos P. Argyropoulos
Journal of Clinical Medicine. 2022;11(20):6051   Crossref logo
Link1
The efficacy and safety of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: a systematic review and meta-analysis
C. Alves, A. Penedones, D. Mendes, F. Batel Marques
Clinical Therapeutics. 2015;37(8):e123-e124   Crossref logo
Link1 Link2
Considerations for best practices related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels
Elizabeth Van Dril, Christine Schumacher
American Journal of Health-System Pharmacy. 2021;   Crossref logo
Link1 Link2 Link3
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
Tamara Y. Milder, Sophie L. Stocker, Richard O. Day, Jerry R. Greenfield
Drug Safety. 2020;43(12):1211-1221   Crossref logo
Link1 Link2 Link3
Gout and sodium‐glucose cotransporter‐2 inhibitors
Shih‐Wei Lai
Pharmacoepidemiology and Drug Safety. 2021;31(1):112-113   Crossref logo
Link1 Link2 Link3